Volume 13 Issue 11 - 2021
An Approach to Psychiatric Disorders in the Patient with Epilepsy
Juan E Bender del Busto*
Philosopher Doctor, Second Degree Specialist in Neurology, Full Professor and Researcher, International Center of Neurological Restoration (CIREN), Havana, Cuba
*Corresponding Author: Juan E Bender del Busto, Philosopher Doctor, Second Degree Specialist in Neurology, Full Professor and Researcher, International Center of Neurological Restoration (CIREN), Havana, Cuba.
Received: October 11, 2021; Published: October 29, 2021

In this comment, we will try to expose an issue that relates Psychiatry and Neurology, by reviewing the psychiatric disorders that may occur in the patient with epilepsy, which are not taken into account in the management of the patient and therefore with unsatisfactory evolution.

Epilepsy is one of the most frequent Central Nervous System (CNS) disorders [1] and a disease known since ancient times. It is a global health problem [2], with an estimated 50 to 69 million people suffering from it [3-5].


  1. Bender JE. “Evaluación clínica prey postquirúrgica de pacientes con epilepsia refractaria”. Editorial Universitaria Cubana (2012).
  2. Bender del Busto JE. “La epilepsia, un problema de salud a escala mundial”. Revista Habanera de Ciencias Médicas5 (2018).
  3. Neurological Disorders: Public Health Challenges. Chapter 3. Neurological disorders a public health approach. World Health Organization (2014).
  4. En: Guía Clínica Auge. Epilepsia adultos. 3rd edition (2014).
  5. Linehan C and Berg A. “Epidemiologic aspects of epilepsy”. In: Wyllie’s Treatment of Epilepsy Principles And Practice. 6th Copyright © 2015 Wolters Kluwer (2015).
  6. Falcone T and Palombaro AM. “Quality of life with epilepsy”. In: Wyllie’s Treatment of Epilepsy Principles And Practice. 6th Copyright © 2015 Wolters Kluwer (2015).
  7. Bender Del Busto JE. “Atención al paciente con epilepsia”. Editorial Universitaria UNAN-Leon (2014).
  8. Meador KJ. “Cognitive effects of epilepsy and its treatments”. In: Wyllie´s Treatment of Epilepsy. Principles and practice. 6th Wolters Kluwer (2015).
  9. Krauskopf V and De la Barra F. “Trastornos psiquiátricos en los pacientes con epilepsia”. Revista Médica Clínica Las Condes6 (2013): 979-985.
  10. Bender del Busto JE. “Epilepsy on the Border of Psychiatry and Neurology”. CPQ Neurology and Psychology3 (2019): 01-14.
  11. Tao K and Wang X. “The comorbidity of epilepsy and depression: diagnosis and treatment”. Expert Review of Neurotherapeutics 16 (2016): 1321-1333.
  12. Zapata Barco AM and Restrepo-Martínez M y Restrepo D. “Depresión en personas con epilepsia. ¿Cuál es la conexión?” r e v c o l o m b p s i q u i a t1 (2020): 53-61.
  13. Definición de Epilepsia y de las crisis. En: Guía Clínica Auge. Epilepsia adultos. 3rd edition (2014).
  14. Robert S Fisher., et al. “A practical clinical definition of epilepsy”. Epilepsia 4 (2014): 475-482.
  15. Reilly C., et al. “Review: Psychopathology in childhood epilepsy”. Child and Adolescent Mental Health 2 (2013): 65-75.
  16. Devinsky O. “Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment”. Epilepsy and Behavior 4 (2003): 2-12.
  17. Vuilleumire P and Jallon P. “Epilepsy and psychiatric disorders: epidemiological data”. Revue Neurologique 154.4 (1998): 305-317.
  18. Tsopelas N., et al. “The relationship of psychiatric illnesses and seizures”. Current Rheumatology Reports Medicopsychiatr Disord 3 (2001): 235-242.
  19. Tucker G. “Seizure disorders presenting with psychiatric symptomatology”. Psychiatric Clinics of North America3 (1998): 625-635.
  20. Devinsky O and Theodore W. “Epilepsy and behavior”. New York: Wiley-Liss (1991).
  21. Psiquiatria y Epilepsia en el adulto. En: Guía Clínica Auge. Epilepsia adultos. 3rd edition (2014).
  22. Rossiñol A., et al. “Calidad de vida y percepción de salud general de personas con epilepsia en función de las crisis, la afectación neurocognitiva, la electroencefalografía, su respuesta al tratamiento y los efectos secundarios”. Revue Neurologique1 (2013): 17-24.
  23. Martínez-Dominguez S., et al. “Enfermedad mental, rasgos de personalidad y calidad de vida en epilepsia: estudio control de pacientes con epilepsia mioclónica juvenil y otras epilepsies”. Revue Neurologique12 (2013): 608-614.
  24. Marchetti RL., et al. “Epilepsia y Trastornos Mentales”. Revista de Psiquiatría Clínica3 (2005): 170-182.
  25. Sackellares JC and Berent S. “Psychological Disturbances in Epilepsy”. Neurology1 (2000): 8-14.
  26. Hermann B and Whitman S. “Behavioral and personality correlates of epilepsy: a review, methodological critique, and conceptual model”. Psychological Bulletin 95 (1984): 451-497.
  27. Hermann B and Whitman S. “Neurobiológical, psychosocial and pharmacological factors underlying interictal psychopatology in epilepsy”. New York: Raven Press (1991).
  28. Hermann B., et al. “Psychiatric comorbility in chronic epilepsy: identification, consequences, and treatment of mayor depression”. Epilepsia (2000): 41.
  29. Schmitz E., et al. “Depression and schizophrenia in epilepsy: social and biological risk factors”. Epilepsy Research 1 (1999): 59-68.
  30. Zapata Barco AM., et al. “Depresión en personas con epilepsia. ¿Cuál es la conexión?” r e v c o l o m b p s i q u i a t 4 9.1 (2020): 53-61.
  31. Leeman-Markowski BA and Schachter SC. “Psychiatric Comorbidity of Epilepsy In: Wyllie’s Treatment of Epilepsy Principles And Practice. 6th Copyright © 2015 Wolters Kluwer (2015).
  32. Tellez-Zenteno J., et al. “Psychiatric comorbility in epilepsy: a population-based analysis”. Epilepsia (2007): 233-244.
  33. Martinez-Pérez B., et al. “Depresión y Epilepsia”. Revue Neurologique 6 (2002): 580-586.
  34. Castaño-Monsalve B. “Antidepresivos en epilepsia”. Revue Neurologique 5 (2013): 117-122.
  35. González-Pal S., et al. “Depresión en grupos de pacientes con epilepsias focales”. Revista del Hospital Psiquiátrico de La Habana (2007): 4.
  36. Kanner AM. “Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?” Current Neurology and Neuroscience Reports 9 (2009): 307-312.
  37. Beghi M., et al. “Epilepsy in psychiatric disorders”. En: Mula M, editor. Neuropsychiatric symptoms of epilepsy, neuropsychiatric symptoms of neurological disease. Geneva: Springer International (2016).
  38. Boylan LS., et al. “Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy”. Neurology 2 (2004): 258-261.
  39. Goldney RD. “Suicide prevention”. Recurso electrónico: Oxford New York Oxford University Press (2008).
  40. Palacios-Espinosa X and Palacios Sánchez L. “Epilepsia y suicidio: una revisión del tema”. Acta Neurológica Colombiana 3 (2016): 260-271.
  41. Trimble M. “Treatment issues for personality disorders in epilepsy”. Epilepsia1 (2013): 41-45.
  42. Chou IC., et al. “Correlation between epilepsy and attention deficit hyperactivity disorder: a population-based cohort study”. PLoS One 3 (2013): e57926.
  43. Andrade-Machado R., et al. “Suicidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractory epilepsy”. Epilepsy and Behavior 45 (2015): 254-260.
  44. González-Pal S., et al. “Ansiedad en un grupo de pacientes con epilepsia, estudio de variables biológicas y farmacológicas” 8.4 (2004).
  45. Maroufi A., et al. “Prevalence and quality of anxiety in patients with epilepsy”. Epilepsy and Behavior 32 (2014): 34-37.
  46. Ramasubbu R., et al. “The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions”. Annals of Clinical Psychiatry1 (2012): 91-109.
  47. Beyenburg S., et al. “Anxiety in patients with epilepsy: systematic review and suggestions for clinical management”. Epilepsy and Behavior2 (2005): 161-171.
  48. Nenadovic M., et al. “Anxiety in epileptic patients”. Psychiatria Danubina3 (2011): 264-269.
  49. Mula M. “Treatment of anxiety disorders in epilepsy: an evidence-based approach”. Epilepsia1 (2013): 13-18.
  50. Vicentic S., et al. “Analysis of Quality of Life and Anxiety in patients with differents forms of Epilepsy”. Israel Journal of Psychiatry and Related Sciences1 (2013): 55-60.
  51. Tang WK., et al. “Anxiety symptoms in patients with frontal lobe epilepsy versus generalized epilepsy”. Seizure6 (2012): 457-460.
  52. Piazzini A., et al. “Aggressive behavior and epilepsy: a multicenter study”. Epilepsia10 (2012): e174-e179.
  53. Helmstaedter C and Witt JA. “Multifactorial etiology of interictal behavior in frontal and temporal lobe epilepsy”. Epilepsia 10 (2012): 1765-1773.
  54. Waxman SG and Geschwind N. “The interictal behavior syndrome of temporal lobe epilepsy”. Archives Of General Psychiatry 12 (1975): 1580-1586.
  55. D´ Alessio L., et al. “Psicosis y epilepsia: características clínicas y abordaje terapeútico”. Revista Argentina Psiquiatr 23 (2012): 265-270.
  56. De Araujo Filho GM., et al. “Psychoses of epilepsy: a study comparing the clinical features of patients with focal versus generalized epilepsies”. Epilepsy and Behavior 4 (2011): 655-658.
  57. Hilger E., et al. “Postictal psychosis in temporal lobe epilepsy: a case–control study”. European Journal of Neurology 6 (2013): 955-961.
  58. Kanner AM and Rivas-Grajales AM. “Psychosis of epilepsy: a multifaceted neuropsychiatric disorder”. CNS Spectrums 3 (2016): 247-257.
  59. , et al. “The prevalence of psychosis in epilepsy; a systematic review and metaanalysis”. BMC Psychiatry 14 (2014): 75.
  60. Rojas-Valverde LD and Rojas-Valverde D. “Intervención terapéutica del fenómeno de normalización forzada/ Rojas-Valverde L. y cols. ISSN 2215-5562”. Ter. Enero-Junio de 15.1 (2021): 134-140.
  61. González Mingot C., et al. “Epileptic peri-ictal psychosis, a reversible cause of psychosis”. Neurologia2 (2013): 81-87.
  62. Hilger E., et al. “Psychoses in epilepsy: A comparison of postictal and interictal psychoses”. Epilepsy and Behavior 60 (2016): 58-62.
  63. Goicochea A., et al. “Complicaciones psiquiátricas en la epilepsia del lóbulo temporal: clasificaciones, el trastorno psicótico como complicación. En: Epilepsias del lóbulo temporal”. Medellín-Colombia (2011).
  64. Gonzalez C., et al. “Psicosis epiléptica periictal, una causa de psicosis reversible”. Neurologia2 (2013): 81-87.
  65. Van Lutterveld R., et al. “The neurophysiology of auditory hallucinations - a historical and contemporary review”. Frontiers in Psychiatry 2 (2011): 28.
  66. Hellwig S., et al. “Psychiatric comorbidity in patients with pharmacoresistant focal epilepsy and psychiatric outcome after epilepsy surgery”. Epilepsy and Behavior 3 (2012): 272-279.
  67. Hamid H., et al. “Suicide outcomes after resective epilepsy surgery”. Epilepsy and Behavior 3 (2011): 462-464.
  68. Macrodimitris S., et al. “Psychiatric outcomes of epilepsy surgery: a systematic review”. Epilepsia 5 (2011): 880-890.
  69. Quigg M., et al. “Neuropsychological outcomes after Gamma Knife radiosurgery for mesial temporal lobe epilepsy: a prospective multicenter study”. Epilepsia 5 (2011): 909-916.
Citation: Juan E Bender del Busto. “An Approach to Psychiatric Disorders in the Patient with Epilepsy”. EC Neurology 13.11 (2021): 29-34.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 15, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.